Skip to content

Efficacy of Homoeopathic Medicine Rhus tox. on knee Joint pain.

Efficacy of Rhus tox. vis- -vis individualised Homoeopathic medicines on joint pain due to knee osteoarthritis: A Randomised Double Blind Placebo Controlled multicentric Clinical Trial. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105682
Enrollment
150
Registered
2026-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Rhus tox30/200/1M: Rhus tox 30 4globules,twice daily for 3 days in 15 days intervals will be given in an empty stomach for 12 months by oral route. Potency will be increased as per nee

Sponsors

Central Council for Research in Homoeopathy,New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Both male and female age from 40-70 years. 2-Radiologically confirmed cases of osteoarthritis (Grade-1 to Grade-3 as per Kellgren and Lawrence grading system) or fulfilling the criteria of American College of Rheumatology for diagnosis of OA of Knee. 3-Complaints of pain - aggravation from initial motion & amelioration from continued motion. 4-Cases with controlled DM and HTN. 5-Cases with written informed consent.

Exclusion criteria

Exclusion criteria: 1-Cases of below 40 years of age and above 70 years 2-Cases with joint deformities like Grade-4 OA cases. 3-Cases with Gout. 4-Cases with Psoriatic Arthritis. 5-History of known life threatening disease/systemic illness (tuberculosis, cancer, AIDS, diabetes, hypertension, cardiovascular disorders etc.) 6-Cases taking medication for any severe other illness. 7-Intra-articular injections within 2 wk before study entry. 8-Recent significant knee surgery within last 6 month. 9-Cases with transplanted knees

Design outcomes

Primary

MeasureTime frame
Primary outcomes- Clinical assessment of joint pain through WOMAC index and KOOS at baseline, 6 months, 1 year and by ORIDL at every month. Timepoint: six months, one year

Secondary

MeasureTime frame
Secondary outcomes- Quality of Life through SF-36 arthritis specific health index (ASHI) at baseline, 6 months, 1 year. To assess the effect on progression of osteoarthritis through radiological/MRI investigation with grading as per Kellgren and Lawrence grading system at baseline, at the end of 6th months and 1 year of treatment. Timepoint: six months, one year

Countries

India

Contacts

Public ContactDr Akhyaya kumar prusty
prustyakshayakumar@gmail.com06752222711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026